Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: exercise plus diet restriction, diet restriction.
- Who it may be relevant to
- Registry conditions: Familial Mediterranean Fever, Non-Alcoholic Fatty Liver Disease. Basic parameters: 30 years — 55 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Elliptical Aerobic Exercise
Overview
Familial Mediterranean fever (FMF) affect liver and causes some dysfunctions including non-alcoholic fatty liver.. still exercise and diet limitation is the treatment for this case
Detailed description
Familial Mediterranean fever (FMF women with fatty liver) will be collected to be cateogarized to group I or group II. Every group OF FMF will contain 20 FMF women. Both groups will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months. Group I will also perform elliptical aerobic exercise (this exercise will be applied for 40 minutes three times weekly and this exercise will be maintained for 6 months)
Interventions
- Behavioral exercise plus diet restriction
Familial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months. also, this group, Group I, will also perform elliptical aerobic exercise (this exercise will be applied for 40 minutes three times weekly and this exercise will be maintained for 6 months) - Behavioral diet restriction
Familial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months.
Primary outcome measures
- aspartate transaminase [Time frame: it will be measured after 6 months]
Secondary outcome measures (9)
- alanine transaminase [Time frame: it will be measured after 6 months]
- body mass index [Time frame: it will be measured after 6 months]
- waist circumference [Time frame: it will be measured after 6 months]
- high density lipoprotein [Time frame: it will be measured after 6 months]
- triglycerides [Time frame: it will be measured after 6 months]
- cholesterol [Time frame: it will be measured after 6 months]
- low density lipoprotein [Time frame: it will be measured after 6 months]
- c reactive protein [Time frame: it will be measured after 6 months]
- erythrocyte sedimentation rate [Time frame: it will be measured after 6 months]
Eligibility criteria
Inclusion criteria
- familial Mediterrean fever women
- obese women
- women who have fatty live (non alcoholic type)
Exclusion criteria
- cardiac patients
- respiratory disease
- renal disease
- cancer
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- faculty of physical therapy Cairo university — Dokki
Identifiers
NCT: NCT07130318 · IRB00014233-34